drugset / Trial / NCT00271271

Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients

NCT00271271 ↗

Phase 2 Completed 40 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Primary: ·To evaluate the activity of the combination of gemcitabine, oxaliplatin and vinorelbine as first line treatment in patients with non-small cell bronchopulmonary cancer Secondary: ·To evaluate the toxicity of the combination

Timeline

Start
2003-06
Primary completion
—
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — —
Subject Oxaliplatin Small molecule — —
Subject Vinorelbine Small molecule — —